This week's top news includes Pharma's response to the 2024 UK General Election, and what is the best way forward for botanical drugs?
European Pharmaceutical Review
The leading FREE journal for all aspects of drug analysis, formulation, delivery, manufacturing and regulation.
The Association of the British Pharmaceutical Industry (ABPI) and Drug Safety Research Unit (DSRU) assert the importance of partnership and collaboration to support the pharmaceutical industry under the new UK government. Read now.
The investigators hope that their new approach could lead to large-scale manufacturing of the CAR T cells for blood cancer patients. Read now.
In this article, Taly Dvorkis , Life Sciences Regulatory Director at Fieldfisher, explores the different pathways available for market approval of botanical drugs in the US, UK and the EU. Read now.
?? What to watch
Why should you attend?
? Define a digital strategy as part of your clinical development programme
? Learn why the expanded use of digital measures and biomarkers will continue to accelerate clinical development timelines.
? Discover how global pharmaceutical companies are benefiting from Medable’s novel approaches and technology to accelerate decision-making in oncology
?? What to read
Learn more about:
领英推荐
? How automation and single-use systems are helping to drive down CGT costs and development timelines
? Defining a chemistry, manufacturing and controls (CMC) strategy
? Quality perspectives in navigating development of cell therapy programmes
? Environmental monitoring requirements for ATMP manufacturing facilities
This in-depth focus features articles on:
? Cleanroom microbiology: single temperature incubation for EM
? Endotoxin standards: reflection and recommendation
? Improving aseptic connections throughout the manufacturing process
European Pharmaceutical Review is an essential resource for students, researchers and industry professionals looking for the latest industry insights and innovations.